This July, EBS will be attending ADLM 2026, one of the world’s largest events for laboratory medicine and diagnostics. We’re excited to introduce our next-generation automated allergy testing platform and connect with laboratory professionals, distributors, and industry partners from around the world.
Over the past few years, allergy testing has become increasingly important as allergy-related conditions continue to rise globally. At the same time, laboratories are under pressure to handle more samples with limited staff and resources. This growing demand highlights the need for automated solutions that can improve laboratory efficiency and optimize workflow.
Our automated allergy testing platform combines EBS’s Protein MicroArray technology with automated processing, scanning, analysis, and digital reporting in a single workflow. Designed to simplify laboratory operations, the system can process close to 100 samples per day and deliver results in approximately three hours per run.
Depending on the selected testing panel, each sample can be screened for 66 to 123 allergens, helping laboratories provide comprehensive allergy testing while improving efficiency.
One feature we’re especially proud of is the platform’s flexibility. The same system can be used for both human and pet allergy testing, giving laboratories the ability to expand their services without investing in separate testing platforms.
ADLM 2026 represents an exciting milestone for EBS as we continue expanding internationally. We’re looking forward to sharing our technology with the global diagnostics community and exploring new opportunities for collaboration across human and veterinary diagnostics.
If you’ll be attending ADLM 2026, we invite you to stop by and learn more about how EBS is helping laboratories deliver allergy testing more efficiently than ever.
 |
EBS ADLM 2026 Visitor FormThank you for visiting the EBS booth at ADLM 2026. |
